Benemedo
Benemedo is a Prague-based pharmaceutical services provider offering sales-representation, distribution, and market-entry services for pharma and cosmetic companies across 14+ countries in Central, Eastern, and South-Eastern Europe, alongside its own proprietary dermatology brands (Vitella, Mediket, and others) positioned as Swiss-made products.
- Company typePrivate
- Founded2002
- HeadquartersPrague, Czechia
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Benemedo does
Benemedo s.r.o. is a Prague-headquartered pharmaceutical services company founded in 2002 (originally as Taktika) that operates across 14+ countries in Central, Eastern, and South-Eastern Europe (Czech Republic, Poland, Romania, Switzerland, Slovakia, Bulgaria, Hungary, Ukraine, Belarus, Moldova, Slovenia, Serbia, Croatia, Lithuania, Azerbaijan, and Armenia), with regional offices in Warsaw, Bucharest, and Lachen, Switzerland. The company maintains legal entities in the Czech Republic (Benemedo s.r.o.), Poland (Benemedo Sp. z o.o.), and Switzerland (Benemedo GmbH), and operates 11-50 employees.
The company runs a dual business model. On the B2B side, it offers foreign pharmaceutical and cosmetic companies a single-entity entry point into CEE markets via sales-representation, co-promotion, co-marketing, and distribution services, supported by an in-region sales team and established pharmacy/wholesale channels. On the proprietary-products side, Benemedo develops and markets its own dermatological and dermocosmetic brands under a 'Swiss-made' positioning, principally Vitella (skincare pastes, gels, creams, and lotions for conditions such as acne, seborrhea, atopic dermatitis, tinea versicolor, and skin regeneration) and Mediket (anti-dandruff shampoos and scalp/body cleansers), with additional lines including Ortholan massage gel, Otivet/Medivet veterinary dermatology products, and the Benemedio 301 anti-aging serum. Differentiated formulations include ozonized olive oil in Vitella Treox and white ichthyol across the Ictamo and Ictamo Forte SKUs.
Revenue is generated through two streams: (1) one-time product sales of proprietary OTC/dermatocosmetic SKUs distributed through pharmacy networks across the region, and (2) professional services revenue from sales-representation and distribution contracts with partner pharma and cosmetic manufacturers. Pricing is not publicly disclosed. The company reaches end customers and partners via an eight-language website footprint (English, Czech, Slovak, Polish, Romanian, Bulgarian, Lithuanian, French) and dedicated brand microsites (vitella.ch, mediket.ch, benevet.ch, benemedio.ch). No app, public API, or AI/ML capabilities are present in the public record.
Benemedo firmographics
Firmographics- Name
- Benemedo
- Legal name
- Benemedo s.r.o.
- Website
- https://benemedo.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Benemedo is a Prague-based pharmaceutical services provider offering sales-representation, distribution, and market-entry services for pharma and cosmetic companies across 14+ countries in Central, Eastern, and South-Eastern Europe, alongside its own proprietary dermatology brands (Vitella, Mediket, and others) positioned as Swiss-made products.
- Ownership category
- akta.pro rank
Benemedo industry classification
Industry- Product category
- Dermatological Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)
- akta.pro secondary industries
- Dermatology & Topical Skin Treatments (HLAIADAE), Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where Benemedo is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices4 records
Markets served
Benemedo business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Pharmaceutical Product Sales: Benemedo generates revenue through the sale of proprietary pharmaceutical and dermatocosmetic product lines including Vitella (dermatology products) and Mediket (scalp and skin care products).
- Pharmaceutical Services: Revenue is generated through partnership services including sales representation, marketing support, and distribution services for pharmaceutical and cosmetic companies entering Central, Eastern, and Southeast European markets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Benemedo product offering
Product offeringCore offering
Benemedo is a pharmaceutical services provider operating across Central, Eastern, and South-Eastern Europe. The company develops and markets its own dermatological and dermatocosmetic product lines (Vitella, Mediket, Ortholan, Otivet, Medivet, Benemedio 301) covering skincare, scalp care, and veterinary applications. In parallel, Benemedo provides sales representation, marketing, and distribution services that enable pharmaceutical and cosmetic companies from Europe, North America, and Asia to enter and grow in CEE markets through a single entity.
Product overview
Benemedo is a leading pharmaceutical services provider operating in Central, Eastern, and South-Eastern Europe, offering a portfolio of dermatological and dermocosmetic products. The company provides its own product lines developed through ongoing research and development, with key brands including Vitella (skincare products including healing pastes, gels, creams, and lotions for conditions like acne, seborrhea, atopic dermatitis, and skin regeneration) and Mediket (scalp and body care products including shampoos, gels, and foams for dandruff treatment and skin conditions). Additional products include Benemedio 301 (anti-aging serum), Ortholan gel (massage gel for musculoskeletal care), Otivet (veterinary ear cleansing solution), and Medivet (veterinary shampoo for animal skin conditions). The company positions its products as Swiss-made care and works with pharmaceutical and cosmetic partners across Europe, North America, and Asia.
Differentiator
Problem solved
Functional benefit
Brands
- Vitella: Swiss-made dermatological skincare products including Ictamo, Ictamo Forte, Versi, Extreme, Zn, Treox, U, Vein, and Ictogel for various skin conditions.
- Mediket
- Ortholan
- Otivet
- Medivet
- Benemedio 301
Products and services
- Vitella Ictamo
Companies that use Benemedo
Customer profileSegments3 records
Ideal customer profiles3 records
Benemedo technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Benemedo partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor and core.
- 3 – ChennésminorSelected partner based in Lyon, France. Provides hair color and beauty products through www.barvy-vlasy.cz.
- Smart PracticeminorSelected partner based in Phoenix, USA. Associated with www.truetest.info.pl for diagnostic/testing products.
- Key Pharmaceutical and Cosmetic CompaniescoreBenemedo builds strong partnerships with key pharmaceutical and cosmetic companies from Europe, North America, and Asia, providing market entry and distribution services in Central, Eastern, and South-Eastern Europe. They create and maintain long-term business relationships.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
Benemedo competitors and assessment
Company assessmentBroad incumbents
- Perrigo Company: Global OTC and self-care pharmaceutical company with European consumer-health portfolio including skin care, scalp care and dermatology products. Broad incumbent that competes with Benemedo's Vitella/Mediket categories on European pharmacy shelves.
- Bayer Consumer Health: Global consumer-health division of Bayer with extensive OTC dermatology, scalp-care and skincare brands (e.g., Bepanthen, Canesten). Broad incumbent whose dermatology portfolio competes directly with Benemedo's Vitella and Mediket lines across CEE/SEE pharmacy shelves.
- Stada Arzneimittel: Large German-based generics and OTC pharmaceutical group with broad consumer-health portfolio including dermatology, cough/cold and pain relief sold across CEE/SEE markets. Broad incumbent overlapping Benemedo's categories and geographies at meaningfully larger scale.
Direct peers
- Almirall: Spanish pharmaceutical company specialized in dermatology, offering prescription and OTC skin-care products across European markets. Direct peer to Benemedo's Vitella dermatology portfolio, with similar focus on topical treatments for skin conditions.
- Galderma: Global dermatology-focused pharmaceutical company offering prescription and OTC skin-care products including acne, eczema and sensitive-skin treatments. Directly comparable to Benemedo's dermatology platform in therapeutic area, though operating at much larger scale.
- Dermapharm Holding: German specialty pharmaceutical company focused on dermatology and allergy products with branded generics and OTC lines. Highly comparable to Benemedo: both develop and distribute proprietary dermatology/skin-care pharmaceutical products, including OTC anti-fungal and anti-inflammatory formulations.
- KRKA: Slovenian generic and OTC pharmaceutical manufacturer with strong CEE/SEE and CIS distribution network. Comparable to Benemedo as a regional CEE pharma with own product lines and direct pharmacy distribution across overlapping markets.
- Pierre Fabre: French dermo-cosmetics and pharmaceutical company with dermatology and skin-care product lines distributed across European markets. Comparable to Benemedo on the dermatocosmetics side of its portfolio, including anti-dandruff and sensitive-skin product categories.
- Zentiva: Czech-headquartered generics and OTC pharmaceutical group with deep CEE distribution footprint and brand-building history. Directly comparable to Benemedo in both therapeutic focus (dermatology/skin OTC) and CEE/SEE regional presence.
Regional players
- Polpharma: Polish pharmaceutical manufacturer and one of the largest CEE producers of generics and OTC products including dermatology lines. Comparable to Benemedo on CEE regional focus, dermatology category, and pharmacy distribution model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Benemedo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Benemedo leadership team
Management profileNumber of profiles
Profiles8 records
Benemedo funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Benemedo M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Benemedo
What does Benemedo do?
Benemedo is a pharmaceutical services provider operating across Central, Eastern, and South-Eastern Europe. The company develops and markets its own dermatological and dermatocosmetic product lines (Vitella, Mediket, Ortholan, Otivet, Medivet, Benemedio 301) covering skincare, scalp care, and veterinary applications. In parallel, Benemedo provides sales representation, marketing, and distribution services that enable pharmaceutical and cosmetic companies from Europe, North America, and Asia to enter and grow in CEE markets through a single entity.
Is Benemedo a public or private company?
Benemedo is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Benemedo founded?
Benemedo was founded in 2002. It employs 11 to 50 people.
Where is Benemedo based?
Benemedo is headquartered in Prague, Czechia, in the Europe region.
How does Benemedo make money?
Two revenue lines are on record. Pharmaceutical Product Sales are the primary driver. The others are pharmaceutical Services.
Who are Benemedo's main competitors?
Broad incumbents on record are Perrigo Company, Bayer Consumer Health and Stada Arzneimittel. Direct peers are Almirall, Galderma, Dermapharm Holding, KRKA, Pierre Fabre and Zentiva. Polpharma is listed as a regional player.
Does Benemedo have an API?
No public API is recorded for Benemedo.
What industry is Benemedo in?
Benemedo's product category is Dermatological Pharmaceuticals. Its primary akta.pro industry code is CRADAMAF, Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal), with a secondary code of HLAIADAE, Dermatology & Topical Skin Treatments. Its NAICS code is 325412 and its SIC code is 2834.